Sofwave Medical Ltd (SOFW) - Net Assets
Based on the latest financial reports, Sofwave Medical Ltd (SOFW) has net assets worth ILA35.33 Million ILA (≈ $94.73K USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA58.30 Million ≈ $156.30K USD) and total liabilities (ILA22.97 Million ≈ $61.57K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. For live market cap and overall valuation, see Sofwave Medical Ltd (SOFW) total market value.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ILA35.33 Million |
| % of Total Assets | 60.6% |
| Annual Growth Rate | N/A |
| 5-Year Change | -29.95% |
| 10-Year Change | N/A |
| Growth Volatility | 1104.82 |
Sofwave Medical Ltd - Net Assets Trend (2018–2025)
This chart illustrates how Sofwave Medical Ltd's net assets have evolved over time, based on quarterly financial data.
Annual Net Assets for Sofwave Medical Ltd (2018–2025)
The table below shows the annual net assets of Sofwave Medical Ltd from 2018 to 2025. See SOFW equity financing ratio to measure how much of total assets are equity-financed.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ILA32.72 Million ≈ $87.71K |
+33.39% |
| 2024-12-31 | ILA24.53 Million ≈ $65.75K |
-6.90% |
| 2023-12-31 | ILA26.34 Million ≈ $70.62K |
-18.54% |
| 2022-12-31 | ILA32.34 Million ≈ $86.70K |
-30.75% |
| 2021-12-31 | ILA46.70 Million ≈ $125.21K |
+2946.44% |
| 2020-12-31 | ILA1.53 Million ≈ $4.11K |
-62.75% |
| 2019-12-31 | ILA4.12 Million ≈ $11.03K |
+759.46% |
| 2018-12-31 | ILA-624.00K ≈ $-1.67K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Sofwave Medical Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4883390600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ILA2.00K | 0.01% |
| Other Comprehensive Income | ILA14.00 Million | 42.79% |
| Other Components | ILA71.26 Million | 217.82% |
| Total Equity | ILA32.72 Million | 100.00% |
Sofwave Medical Ltd Competitors by Market Cap
The table below lists competitors of Sofwave Medical Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Wuxi Lihu Corporation Limited Class A
SHE:300694
|
$334.48 Million |
|
Solus Advanced Materials Co Ltd
KO:336370
|
$334.50 Million |
|
Ronshin Group A
SHE:301231
|
$334.57 Million |
|
Zhejiang Xinguang Pharmaceutical Co Ltd
SHE:300519
|
$334.57 Million |
|
Shenzhen Wenke Landscape Co Ltd
SHE:002775
|
$334.29 Million |
|
GuangZhou Wahlap Technology Corporation Limited
SHE:301011
|
$334.28 Million |
|
Radium Life Tech Co Ltd
TW:2547
|
$334.26 Million |
|
Shanxi C&Y Pharmaceutical Group Co Ltd
SHE:300254
|
$334.22 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Sofwave Medical Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 24,526,000 to 32,715,789, a change of 8,189,789 (33.4%).
- Net income of 5,939,517 contributed positively to equity growth.
- New share issuances of 378,000 increased equity.
- Other comprehensive income decreased equity by 62,095.
- Other factors increased equity by 1,934,367.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ILA5.94 Million | +18.15% |
| Share Issuances | ILA378.00K | +1.16% |
| Other Comprehensive Income | ILA-62.09K | -0.19% |
| Other Changes | ILA1.93 Million | +5.91% |
| Total Change | ILA- | 33.39% |
Book Value vs Market Value Analysis
This analysis compares Sofwave Medical Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4195.74x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 19452.34x to 4195.74x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | ILA0.18 | ILA3451.00 | x |
| 2020-12-31 | ILA0.04 | ILA3451.00 | x |
| 2021-12-31 | ILA1.99 | ILA3451.00 | x |
| 2022-12-31 | ILA0.95 | ILA3451.00 | x |
| 2023-12-31 | ILA0.77 | ILA3451.00 | x |
| 2024-12-31 | ILA0.71 | ILA3451.00 | x |
| 2025-12-31 | ILA0.82 | ILA3451.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Sofwave Medical Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 18.15%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 6.26%
- • Asset Turnover: 1.70x
- • Equity Multiplier: 1.71x
- Recent ROE (18.15%) is above the historical average (-136.13%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -83.72% | -1239.21% | 0.04x | 1.51x | ILA-3.86 Million |
| 2020 | -762.36% | -272.36% | 0.89x | 3.14x | ILA-11.84 Million |
| 2021 | -14.62% | -31.26% | 0.36x | 1.30x | ILA-11.50 Million |
| 2022 | -60.39% | -54.81% | 0.77x | 1.42x | ILA-22.76 Million |
| 2023 | -31.42% | -16.45% | 1.16x | 1.65x | ILA-10.91 Million |
| 2024 | -18.54% | -7.62% | 1.39x | 1.75x | ILA-7.00 Million |
| 2025 | 18.15% | 6.26% | 1.70x | 1.71x | ILA2.67 Million |
Industry Comparison
This section compares Sofwave Medical Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $38,140,300
- Average return on equity (ROE) among peers: -42.53%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Sofwave Medical Ltd (SOFW) | ILA35.33 Million | -83.72% | 0.65x | $334.30 Million |
| Allmed Solutions Ltd (ALMD) | $14.19 Million | -44.58% | 0.09x | $7.06 Million |
| Erika Carmel Ltd (BCUR) | $15.04 Million | -62.98% | 1.31x | $4.69 Million |
| Bio-View Ltd (BIOV) | $1.55 Million | 72.16% | 8.48x | $20.36 Million |
| Brainsway Ltd (BWAY) | $6.95 Million | -93.20% | 2.39x | $474.42 Million |
| Erech Finance Cahalacha Ltd (EFNC) | $-1.48 Million | 0.00% | 0.00x | $1.21 Million |
| Epitomee Medical Ltd (EPIT) | $33.95 Million | -15.68% | 0.18x | $23.21 Million |
| Erika Carmel-Tech Ltd (ERKA) | $42.67 Million | -76.32% | 0.60x | $5.44 Million |
| Human Xtensions Ltd (HUMX) | $15.51 Million | -184.33% | 0.31x | $2.12 Million |
| Ilex Medical (ILX) | $120.80 Million | 23.88% | 0.59x | $154.77 Million |
| Pulsenmore Ltd (PULS) | $132.23 Million | -44.29% | 0.36x | $22.89 Million |
About Sofwave Medical Ltd
SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin firming and rejuvenation, tissue renewal, treatment of muscle, aging, and other physiological change in Israel, the United States, Europe, Southeast Asia, the Middle East, and internationally. The company offers an ultrasound technology that induces coagulation and … Read more